The SARS-CoV-2 vaccine produced by the US biotechnology company Novavax is 95.6% effective against the original variant of SARS-CoV-2 but also provides protection against the newer […]
(HealthDay)—Outcomes are similar for younger and older adolescents undergoing bariatric surgery, according to a study published online Feb. 1 in Pediatrics.